Racial and Ethnic Disparities in the Incidence and Prevalence of Low Back Pain in the United States: A Systematic Review [0.03%]
美国腰痛流行病学种族和民族差异的系统评价
Colleen A Burke,Rebecca Fillipo,Meira Epplein et al.
Colleen A Burke et al.
Objective: This systematic review synthesizes existing evidence to quantify racial and ethnic disparities in LBP incidence and prevalence in the United States, across stages of chronicity (acute, subacute, and chronic LBP...
Serum soluble mediator signatures of lupus nephritis: histological features and response to treatment [0.03%]
系统性红斑狼疮患者肾活检组织病理与血清可溶性介质谱型及其临床意义
Andrea Fava,Catriona A Wagner,Carla J Guthridge et al.
Andrea Fava et al.
Objective: Lupus nephritis (LN) management remains challenging, and novel noninvasive biomarkers are needed. This study quantified serum soluble mediators in the Accelerating Medicines Partnership (AMP) LN cohort to ident...
Diffusion-Weighted Imaging for the Evaluation of the Sacroiliac Joint in Pediatric Patients [0.03%]
儿科患者骶髂关节扩散加权成像评估
Michael L Francavilla,Timothy G Brandon,Dmitry Khrichenko et al.
Michael L Francavilla et al.
Background: Maturational signal in the sacroiliac joint (SIJ) of skeletally immature youth is often misinterpreted as inflammation. Diagnostic tools that improve specificity are greatly needed. Apparent diffusion coeffici...
Re-thinking Strategies for a Pharmaceutical Approach to Pain-related to Connective Tissue Related Raynaud's Phenomenon in the United States [0.03%]
美国与结缔组织相关的雷诺氏现象相关疼痛的药物治疗策略再思考
Tracy M Frech,Charles G Frech,W David Merryman et al.
Tracy M Frech et al.
Introduction: There are no Food and Drug Administration (FDA) approved therapies for Raynaud's phenomenon (RP) treatment in the United States (U.S.). Clinical trials have been challenged by study design. Important advance...
Development and External Validation of a Multivariable Predictive Model for Progression to Difficult-to-Treat Rheumatoid Arthritis in Biologic-Experienced Patients [0.03%]
生物制剂治疗失败的类风湿关节炎患者向难治性RA进展的预测模型及其外部验证
Misti L Paudel,Nancy Shadick,Michael Weinblatt et al.
Misti L Paudel et al.
Objective: Approximately 20% of patients with rheumatoid arthritis (RA) cycle through multiple therapies without achieving treatment goals and are classified as "difficult-to-treat" RA (D2T-RA); however, no risk-predictio...
Trends in Opioid Prescriptions in Individuals with Axial Spondyloarthritis in the US and UK in the Last Two Decades: Analysis of Electronic Health Records and Insurance Claims Data [0.03%]
过去20年美国和英国轴性脊柱关节炎患者的阿片类药物处方趋势：电子健康记录和保险索赔数据分析
H Berk Degirmenci,Christine E Peloquin,Maggie Westerland et al.
H Berk Degirmenci et al.
Background: Chronic opioid use occurs in 25% of individuals with axial spondyloarthritis (axSpA). Whether introduction of tumor necrosis factor inhibitors (TNFi) influenced secular trends in opioid prescription in axSpA i...
Thinking Outside the Joints: The Impact of Non-Articular Pain on Patient Reported Outcomes in a Prospective Longitudinal Real-World Early RA Cohort [0.03%]
跳出关节思考：非关节痛对早发性类风湿关节炎患者的预后影响的前瞻性长期研究世界真实案例队列分析
Charis F Meng,Marie-France Valois,Yvonne C Lee et al.
Charis F Meng et al.
Objective: We aimed to understand the association of non-articular pain(NAP), regional and widespread, with patient-reported outcomes in early RA(eRA). Me...
Assessment of pain types in recently diagnosed patients with Inflammatory Arthritis [0.03%]
新近诊断的炎性关节病患者的疼痛评估
Zoe Rutter-Locher,Sam Norton,Joseph L Taylor et al.
Zoe Rutter-Locher et al.
Objective: Up to 40% of patients with inflammatory arthritis (IA) experience persistent pain, traditionally thought to be associated with a shift from peripheral to centrally mediated pain during the disease course in som...
The impact of positive lifestyle behaviors on direct healthcare cost savings for low back pain [0.03%]
积极的生活方式行为对降低腰背痛的直接医疗费用的影响
Ye Tian,Katharine E Roberts,Michelle Hall et al.
Ye Tian et al.
Objective: This study aimed to investigate the relationship between a previously purpose-developed lifestyle behavior scale and healthcare cost savings related to low back pain (LBP). ...
Temporal trends in and associations with nonsteroidal anti-inflammatory drug prescription in adult and pediatric patients with inflammatory bowel disease [0.03%]
溃疡性结肠炎和克罗恩病患儿的非甾体抗炎药处方状况及其影响因素分析
Adam S Mayer,Rui Xiao,Andrew Grossman et al.
Adam S Mayer et al.
Objective: Recent inflammatory bowel disease (IBD) treatment guidelines have recommended against NSAID use despite prevalent musculoskeletal symptoms and opioid overuse in this population. Given the discordance between ch...